Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

ASH In Review: Roche Refreshes Hematology Portfolio With Robust New Drugs

Dec 16 2017

• By Emily Hayes

RedBloodCellsOnWhite_1200x675

Related Content

Roche Powers Forward With First-Line Tecentriq In Advanced NSCLC

Dec 07 2017

After MURANO: Roche/AbbVie Map Venclexta's Expansion Past CLL

Dec 13 2017

Roche's Tecentriq-Avastin Combo Improves PFS In Kidney Cancer Too

Dec 11 2017

Roche's Hemlibra Priced And Labeled To Beat Competition, Safety Concern

Nov 17 2017

Non-Inhibitor Data Secure Roche's Competitive Position In Hemophilia A

Nov 20 2017

Related Companies

Roche Holding AG

AbbVie Inc.

Johnson & Johnson

Gilead Sciences, Inc.

Additional Topics

ASEAN Clinical Trials Research & Development Cancer Blood & Coagulation Disorders BioPharmaceutical

More from Clinical Trials

More from R&D

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window